Barclays Maintains Overweight on Zurn Elkay Water Solns, Lowers Price Target to $56

Benzinga · 4d ago
Barclays analyst William Grippin maintains Zurn Elkay Water Solns (NYSE:ZWS) with a Overweight and lowers the price target from $61 to $56.